Home
>
US Stocks
>
Allogene Therapeutics Inc
Allogene Therapeutics Inc
ALLO

Allogene Therapeutics Inc (ALLO)

$15.941.85%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$16.01
Today Low/High$15.89 / $16.19
52 Week Low/High$12.9 / $39.12
Market Cap$2.23B

Company Details

Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer. Led by a management team with significant experience in cell therapy, Allogene is developing a pipeline of 'off-the-shelf' CAR T cell therapy candidates with the goal of delivering readily available cell therapy on-demand, more reliably, and at greater scale to more patients.
OrganisationAllogene Therapeutics Inc
Employees265
IndustryHealth Technology

Discover more

Frequently Asked Questions

What is Allogene Therapeutics Inc (ALLO) share price today?

Can Indians buy Allogene Therapeutics Inc (ALLO) shares?

How can I buy Allogene Therapeutics Inc (ALLO) shares from India?

Can Fractional shares of Allogene Therapeutics Inc (ALLO) be purchased?

What are the documents required to start investing in Allogene Therapeutics Inc (ALLO) stocks?

We are a SEBI registered investement advisor